Barbara Klencke's Net Worth
$643 Thousand
Who is Barbara Klencke?
Barbara Klencke does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Sierra Oncology, Inc., eFFECTOR Therapeutics, Inc., TScan Therapeutics, Inc., and Xencor Inc.
SEC CIK
Barbara Klencke's CIK is 0001647647
Past Insider Trading and Trends
2024 was Barbara Klencke's most active year for acquiring shares with 7 total transactions. Barbara Klencke's most active month to acquire stocks was the month of May. 2022 was Barbara Klencke's most active year for disposing of shares, totalling 11 transactions. Barbara Klencke's most active month to dispose stocks was the month of June. 2020 saw Barbara Klencke paying a total of $72,709.60 for 173,041 shares, this is the most they've acquired in one year. In 2022 Barbara Klencke cashed out on 342,551 shares for a total of $550,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sierra Oncology, Inc. No price found
Chief Medical OfficerBarbara Klencke used to own units in Common Stock but no longer holds any shares there. From 2015 to 2022 Barbara Klencke acquired a total of 167,950 shares in Sierra Oncology, Inc. at a cost of $144,383.80, Barbara also disposed a total of 10,000 shares of Sierra Oncology, Inc. equalling to $550,000.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -15.00K |
$55.00 | -$825,000.00 |
0
|
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
| +162.01% | 9.28K |
$12.24 | $113,447.17 | 15K |
Aug 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
∞
| 229K |
$0.44 | $100,638.30 | 229K |
Aug 22 - Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
eFFECTOR Therapeutics, Inc. (EFTR) Snapshot price: $0.0783
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
TScan Therapeutics, Inc. (TCRX) Snapshot price: $5.55
InvestorBarbara Klencke owns 40,000 units of Voting Common Stock which is worth $222,000.00. In the year 2023 Barbara Klencke acquired a total of 15,000 shares in TScan Therapeutics, Inc. at a cost of $81,500.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.33% | 10K |
$5.61 | $56,100.00 | 40K |
Aug 23 - Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
| +20.00% | 5K |
$5.08 | $25,400.00 | 30K |
Dec 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Xencor Inc (XNCR) Snapshot price: $16.18
InvestorBarbara Klencke owns 5,986 units of Common Stock which is worth $96,853.48. In the year 2023 Barbara Klencke acquired a total of 5,986 shares in Xencor Inc.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.99K |
—
|
—
| 5.99K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||